ArticleFrontiers in pharmacology2018

Evaluation of Tolerability, Pharmacokinetics and Pharmacodynamics of Vicagrel, a Novel P2Y12 Antagonist, in Healthy Chinese Volunteers.

Xiaojiao Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.